The South African Tuberculosis Vaccine Initiative (SATVI) invites applications for the vacancy of Research Officer (Clinical). Closing Date: 4 December 2015.
The South African Tuberculosis Vaccine Initiative has announced its participation in the 46th Union World Conference on Lung Health which will be taking place in Cape Town from 2-6 December 2015.
The South African Tuberculosis Vaccine Initiative has welcomed the release of the 2015 Global TB Report by the World Health Organisation.
The South African Tuberculosis Vaccine Initiative recently vaccinated the first participants in the MTBVAC study, a clinical trial which will evaluate the safety of the novel TB vaccine MTBVAC firstly in adults followed by a dose – escalation trial of the safety and immunogenicity of MTBVAC compared to BCG in newborns.